QID 241406

Date Published: 2023-05-08

QID 241406: Red Hat Update for libreswan (RHSA-2023:2122)

Libreswan is an implementation of ipsec and ike for linux.
Ipsec is the internet protocol security and uses strong cryptography to provide both authentication and encryption services.
These services allow you to build secure tunnels through untrusted networks such as virtual private network (vpn)...Security Fix(es):

    libreswan: malicious ikev1 aggressive mode packets can crash libreswan (cve-2023-30570).
Affected Products:
    Red Hat enterprise linux for x86_64 8 x86_64.
    Red hat enterprise linux for ibm z systems 8 s390x.
    Red hat enterprise linux for power, little endian 8 ppc64le.
    Red hat enterprise linux for arm 64 8 aarch64.
.

Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a security breach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as Critical - 8.6 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution
    Refer to Red Hat security advisory RHSA-2023:2122 for updates and patch information.
    Vendor References

    CVEs related to QID 241406

    CVE-2023-30570 |
    Software Advisories
    Advisory ID Software Component Link
    RHSA-2023:2122 Red Hat Enterprise Linux URL Logo access.redhat.com/errata/RHSA-2023:2122
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].